Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Inspire Medical Systems, Inc. Common Stock
(NY:
INSP
)
64.51
-3.54 (-5.20%)
Official Closing Price
Updated: 7:00 PM EST, Feb 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Inspire Medical Systems, Inc. Common Stock
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022
↗
December 13, 2022
Via
Benzinga
Inspire Medical Systems: Q1 Earnings Insights
↗
May 03, 2022
Inspire Medical Systems (NYSE:INSP) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
December 01, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Inspire Medical Systems's Return On Capital Employed Insights
↗
November 09, 2022
Inspire Medical Systems (NYSE:INSP) brought in sales totaling $109.19 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 16.27%, resulting in a loss of $16.85...
Via
Benzinga
United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday
↗
November 03, 2022
U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Earnings Preview For Inspire Medical Systems
↗
October 31, 2022
Inspire Medical Systems (NYSE:INSP) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Inspire Medical Systems: Q2 Earnings Insights
↗
August 02, 2022
Inspire Medical Systems (NYSE:INSP) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Inspire Medical Systems Earnings Preview
↗
August 01, 2022
Inspire Medical Systems (NYSE:INSP) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Inspire Medical Systems's Earnings Outlook
↗
May 02, 2022
Inspire Medical Systems (NYSE:INSP) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Inspire Medical Systems Stock Scores Relative Strength Rating Upgrade
↗
April 20, 2022
Inspire Medical System stock reached an key technical benchmark, seeing its Relative Strength (RS) Rating jumping to 91.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022
↗
April 13, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
↗
April 06, 2022
Upgrades
Via
Benzinga
Executive Chairman Bill Ford Continues To Buy More Ford Shares
↗
April 04, 2022
I was recently listening to Barry’s Ritholtz’s Masters in Business podcast interview with Darren Palmer, the VP of Ford’s Global EV Program, and he...
Via
Benzinga
Executives Sell Over $640M Of 5 Stocks
↗
March 30, 2022
Although oil futures traded higher on Wednesday, there were a few notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects...
Via
Benzinga
Inspire Medical Clocks 70% Increase In Q4 Sales, Issues FY22 Guidance Ahead Of Consensus
↗
February 09, 2022
Inspire Medical Systems Inc (NYSE: INSP) generated revenue of
Via
Benzinga
Inspire Medical Systems: Q4 Earnings Insights
↗
February 08, 2022
Inspire Medical Systems (NYSE:INSP) reported its Q4 earnings results on Tuesday, February 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
↗
February 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
↗
January 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Annexon Announces Mixed Phase 2 Data From Huntington Disease Trial Annexon,...
Via
Benzinga
Earnings Scheduled For February 8, 2022
↗
February 08, 2022
Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.
Via
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
↗
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
Inspire Medical Expects Strong Q4 FY21 Revenue Growth
↗
January 05, 2022
Inspire Medical Systems Inc (NYSE: INSP) expects Q4 FY21 revenue of $78.0 million - $78.4 million, up approximately 70% Y/Y and surpassing the consensus estimate of $65...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Mixed After Dow Records Another High
↗
January 05, 2022
Pre-open movers U.S. stock futures traded mixed in early pre-market trade after the Dow Jones surged to a new record closing high on Tuesday. Investors are awaiting earnings...
Via
Benzinga
5 Stocks To Watch For January 5, 2022
↗
January 05, 2022
Some of the stocks that may grab investor focus today are: Wall Street expects RPM International Inc. (NYSE: RPM) to report quarterly earnings at $0.83 per share on revenue of...
Via
Benzinga
Atrial Fibrillation Market Is Expected To Reach $11.123 Billion At A CAGR 11.2 % Through 2023
November 04, 2021
Palm Beach, FL – November 4, 2021 – FinancialNewsMedia.com News Commentary – Atrial fibrillation is an ailment in which the heart beats irregularly, unlike the usual heartbeat. The upper chambers of...
Via
FinancialNewsMedia
Topics
Death
Inspire Medical Systems, inc (INSP) Q3 2021 Earnings Call Transcript
↗
November 02, 2021
INSP earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
↗
November 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...
Via
Benzinga
Analyst Ratings For Inspire Medical Systems
↗
September 24, 2021
Analysts have provided the following ratings for Inspire Medical Systems (NYSE:IN...
Via
Benzinga
10 Biggest Price Target Changes For Friday
↗
September 24, 2021
Telsey Advisory Group reduced the price target for NIKE, Inc. (NYSE: NKE) from $180 to $176. NIKE shares fell 4.6% to $152.26 in pre-market trading. Wedbush raised the price...
Via
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
↗
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
↗
September 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Acceleron Pharma Inc. (...
Via
Benzinga
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit